Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy.
Oka
Satoko
S
Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke. satopon@jichi.ac.jp
Muroi
Kazuo
K
Mori
Masaki
M
Matsuyama
Tomohiro
T
Fujiwara
Sin-ichiro
S
Oh
Iekuni
I
Ono
Yoko
Y
Kikuchi
Satoru
S
Sato
Kazuya
K
Ueda
Masuzu
M
Toshima
Masaki
M
Ozaki
Katsutoshi
K
Takatoku
Masaaki
M
Nagai
Tadashi
T
Ozawa
Keiya
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D017408:Guidelines as Topic; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017713:Platelet Transfusion / Q000379:methods*; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000139:chemically induced / Q000150:complications / Q000628:therapy*